![Health / Tuberculosis treatment / Extensively drug-resistant tuberculosis / TB Alliance / Moxifloxacin / Pyrazinamide / RNTCP / Multi-drug-resistant tuberculosis / Tuberculosis / Medicine / Biology Health / Tuberculosis treatment / Extensively drug-resistant tuberculosis / TB Alliance / Moxifloxacin / Pyrazinamide / RNTCP / Multi-drug-resistant tuberculosis / Tuberculosis / Medicine / Biology](https://www.pdfsearch.io/img/3792203b4180619330514ac077cd752f.jpg)
| Document Date: 2015-04-07 12:37:11 Open Document File Size: 323,50 KBShare Result on Facebook
City Pretoria / Brussels / New York / / Company Altana AG / / Country United States / South Africa / Belgium / / / Event FDA Phase / / IndustryTerm health systems / / MedicalCondition TB / XDR-TB / / Organization TB Alliance / / Person Cherise Scott / / Position Director / Pediatric Programs cherise.scott@tballiance.org March / / Product NiX / Pyrazinamide / Pa-824 / /
SocialTag |